Paper41323737
Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt/β-catenin signalling pathway.
Mohammad GH and 6 others. Front Cell Dev Biol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt/β-catenin signalling pathway. Papers, record 41323737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41323737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt/β-catenin signalling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32863216 | The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. | Redox Biol | 2020 | https://conductscience.org/library/papers/32863216 | PubMed |
| 2 | 38498274 | The role of PI3K/Akt signaling pathway in chronic kidney disease. | Int Urol Nephrol | 2024 | https://conductscience.org/library/papers/38498274 | PubMed |
| 3 | 34716298 | Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34716298 | PubMed |
| 4 | 30321484 | P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. | IUBMB Life | 2019 | https://conductscience.org/library/papers/30321484 | PubMed |
| 5 | 33991530 | The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload. | Kidney Int | 2021 | https://conductscience.org/library/papers/33991530 | PubMed |
| 6 | 36932062 | Kidney fibrosis: from mechanisms to therapeutic medicines. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36932062 | PubMed |
| 7 | 23559584 | Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. | J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23559584 | PubMed |
| 8 | 31399975 | Inflammatory Mediators and Renal Fibrosis. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31399975 | PubMed |
| 9 | 33718407 | TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33718407 | PubMed |
| 10 | 34916492 | Targeting PI3K/Akt signal transduction for cancer therapy. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34916492 | PubMed |
| 11 | 25240174 | Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. | Curr Opin Cell Biol | 2014 | https://conductscience.org/library/papers/25240174 | PubMed |
| 12 | 32334125 | Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer? | Cell Mol Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/32334125 | PubMed |
| 13 | 35773269 | Targeting fibrosis, mechanisms and cilinical trials. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35773269 | PubMed |
| 14 | 37564215 | Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37564215 | PubMed |
| 15 | 34604344 | Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism. | Kidney Dis (Basel) | 2021 | https://conductscience.org/library/papers/34604344 | PubMed |
| 16 | 30965656 | Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments. | Biomolecules | 2019 | https://conductscience.org/library/papers/30965656 | PubMed |
| 17 | 30551460 | Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30551460 | PubMed |
| 18 | 36368726 | Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways. | Br J Pharmacol | 2023 | https://conductscience.org/library/papers/36368726 | PubMed |
| 19 | 37159329 | Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis. | FASEB J | 2023 | https://conductscience.org/library/papers/37159329 | PubMed |
| 20 | 34357946 | In Vitro and In Vivo Antifibrotic Effects of Fraxetin on Renal Interstitial Fibrosis via the ERK Signaling Pathway. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/34357946 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985472 | Pericyte-mediated intercellular crosstalk in renal fibrosis: regulatory mechanisms and intervention strategies. | Front Physiol | 2026 | https://conductscience.org/library/papers/42985472 | PubMed |
| 42797299 | Pharmaceutical Strategies for Translating Klotho-Based Therapeutics: From Biologic Developability to Advanced Delivery Systems. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797299 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACTA1 | 58 | PubTator's text mining | https://conductscience.org/library/genes/58 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| KL | 9365 | PubTator's text mining | https://conductscience.org/library/genes/9365 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41323737
GET https://conductscience.org/api/papers/v1/41323737/references?page=2